Galaxamide [L3l;MeLeu2,4P]

General Information


DRACP ID  DRACP04532

Peptide Name   Galaxamide [L3l;MeLeu2,4P]

Sequence  LPlPL

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C22H36N4O4

Absent amino acids  ACDEFGHIKMNQRSTVWY

Common amino acids  LP

Mass  49208

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  2

Net charge  0

Boman Index  984

Hydrophobicity  88

Aliphatic Index  156

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35323457

Title  Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20472

DRACP is developed by Dr.Zheng's team.